Vangelis Karalis - Search Results

Year	Number of Results
2002	2
2003	3
2004	4
2005	1
2006	1
2008	1
2009	1
2010	3
2011	3
2012	4
2013	6
2014	3
2016	1
2017	4
2018	3
2019	4
2020	8
2021	17
2022	15
2023	6
2024	1

1

Paediatric Medicines: Regulatory and Scientific Issues.

Daousani C, Karalis VD. Daousani C, et al. Among authors: karalis vd. Drug Res (Stuttg). 2017 Jul;67(7):377-384. doi: 10.1055/s-0043-109788. Epub 2017 May 18. Drug Res (Stuttg). 2017. PMID: 28521373 Review.

2

Current regulatory approaches of bioequivalence testing.

Karalis V, Macheras P. Karalis V, et al. Expert Opin Drug Metab Toxicol. 2012 Aug;8(8):929-42. doi: 10.1517/17425255.2012.690394. Epub 2012 Jun 11. Expert Opin Drug Metab Toxicol. 2012. PMID: 22681436 Review.

3

Interplay between baroreflex sensitivity, obesity and related cardiometabolic risk factors (Review).

Konstantinidou SK, Argyrakopoulou G, Tentolouris N, Karalis V, Kokkinos A. Konstantinidou SK, et al. Among authors: karalis v. Exp Ther Med. 2022 Jan;23(1):67. doi: 10.3892/etm.2021.10990. Epub 2021 Nov 23. Exp Ther Med. 2022. PMID: 34934438 Free PMC article. Review.

4

3D-Printed Oral Dosage Forms: Mechanical Properties, Computational Approaches and Applications.

Karalia D, Siamidi A, Karalis V, Vlachou M. Karalia D, et al. Among authors: karalis v. Pharmaceutics. 2021 Sep 3;13(9):1401. doi: 10.3390/pharmaceutics13091401. Pharmaceutics. 2021. PMID: 34575475 Free PMC article. Review.

5

Consensus Statement Regarding the Efficacy and Safety of Long-Term Low-Dose Colchicine in Gout and Cardiovascular Disease.

Robinson PC, Terkeltaub R, Pillinger MH, Shah B, Karalis V, Karatza E, Liew D, Imazio M, Cornel JH, Thompson PL, Nidorf M. Robinson PC, et al. Among authors: karalis v. Am J Med. 2022 Jan;135(1):32-38. doi: 10.1016/j.amjmed.2021.07.025. Epub 2021 Aug 18. Am J Med. 2022. PMID: 34416165 Free PMC article. Review.

6

Joint use of population pharmacokinetics and machine learning for optimizing antiepileptic treatment in pediatric population.

Damnjanović I, Tsyplakova N, Stefanović N, Tošić T, Catić-Đorđević A, Karalis V. Damnjanović I, et al. Among authors: karalis v. Ther Adv Drug Saf. 2023 Jun 21;14:20420986231181337. doi: 10.1177/20420986231181337. eCollection 2023. Ther Adv Drug Saf. 2023. PMID: 37359445 Free PMC article.

7

Novel methods to assess bioequivalence.

Karalis V, Symillides M, Macheras P. Karalis V, et al. Expert Opin Drug Metab Toxicol. 2011 Jan;7(1):79-88. doi: 10.1517/17425255.2011.539202. Epub 2010 Dec 1. Expert Opin Drug Metab Toxicol. 2011. PMID: 21118059 Review.

8

Novel scaled bioequivalence limits with leveling-off properties.

Kytariolos J, Karalis V, Macheras P, Symillides M. Kytariolos J, et al. Among authors: karalis v. Pharm Res. 2006 Nov;23(11):2657-64. doi: 10.1007/s11095-006-9107-1. Epub 2006 Oct 18. Pharm Res. 2006. PMID: 17048119

9

The heterogeneous course of drug transit through the body.

Dokoumetzidis A, Karalis V, Iliadis A, Macheras P. Dokoumetzidis A, et al. Among authors: karalis v. Trends Pharmacol Sci. 2004 Mar;25(3):140-6. doi: 10.1016/j.tips.2004.01.008. Trends Pharmacol Sci. 2004. PMID: 15019269 Review. No abstract available.

10

Keeping a critical eye on the science and the regulation of oral drug absorption: a review.

Macheras P, Karalis V, Valsami G. Macheras P, et al. Among authors: karalis v. J Pharm Sci. 2013 Sep;102(9):3018-36. doi: 10.1002/jps.23534. Epub 2013 Apr 9. J Pharm Sci. 2013. PMID: 23568812 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

75 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

75 results

Results by year